Trial Profile

Observational Study of the Treatment and Follow-up of Patients With Type II Diabetes Receiving Bitherapy With or Without Januvia/Xelevia.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sitagliptin (Primary) ; Metformin; Sulfonylureas
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms Odyssee
Sponsors Merck Sharp & Dohme

Most Recent Events

17 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
22 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
14 Mar 2012 Planned end date changed from 1 Mar 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com